Font Size: a A A
Keyword [Antagonist]
Result: 21 - 40 | Page: 2 of 10
21. The Effects Of Calcium Antagonist Verapamil In The Murine Model Of Traumatic Hemorrhagic Shock With Endotoxemia
22. Design Of TNF-α Antagonists Based On The Interaction Between TNF-α And Neutralizing Monoclonal Antibody (Z12)
23. Pharmacokinetic-pharmacodynamic Modeling Of Angiotensin Ⅱ AT1-Receptor Antagonist
24. The Role Of Angiotensin Ⅱ In The Brain Derived Microvascular Endothelial Cell Injury And The Protective Effect Of EXP-2528,a Novel AT1 Receptor Blocker
25. A Study On The Polymorphism Of DRD4exonⅢ 48bp VNTR, DAT1, COMTmet/val, IL-1Ra86bp, IL-1βexon5 Gene And Cognitive Function In Han Chinese Children With Tourette's Syndrome
26. A Control Study Of The Effect Of α4β2 Nicotinic Receptor Competitive Antagonist On Non-selective Attention, Activity, Memory And Expression Of α4β2 Receptor Of SHR-an Animal Model Of Attention Deficit Hypera
27. Study On The Effects Of Eotaxin In Pathogenesis Of Allergic Rhinitis
28. Study On Protective Roles Of Platelet Activating Factor Receptor Antagonist In Intestinal Barrier Function During Endotoxemia In Young Rats
29. Aberrant Expression And Its Mechanism Of SFRP1 And SFRP2-antagonists Of Wnt In Pancreatic Carcinoma
30. Structure-Activity Studies On Different Modifications Of Nociceptin/Orphanin FQ And NOP Antagonist
31. PPARγ Antagonist Discovery And Quantitative Characterization Of 15d-PGJ2 Regulation In PPARγ/TGFβ/Smad2 Pathway
32. The Inhibitory Effect Of CCK Receptor Antagonist In Hippocampal Neurons Of Morphine Withdrawal Rats And Related Signaling Mechanisms
33. The Effects Of Endothelin-1 And Endothelin Receptor Antagonist On The Pathyogenesis Of The Renal Interstitialfibrosis
34. Expression Of The Human Soluble Low Density Lipoprotein Receptor (sLDLR) In Pichina Pastoris And Study Of The Screening Model For Low Density Lipoprotein Receptor Antagonist
35. Effect Of Calcium Antagonist Amlodipine On Apoptosis Of LLC-PK1 Cell
36. The Anti-cerebral Ischemia Effects Of Saponins Of Panax Notoginseng And Its Mechanisms
37. Study On Tumor Suppressor Gene P53 And Its Antagonist Oncogene MDM2 In Acute Leukemia
38. Biochemical Pharmacological Studies On A Novel Progesterone Receptor Antagonist ZXH951 And Its Mechanism Of Action
39. The Effects Of Angiotensin-Ⅱ And Angiotensin-Ⅱ Type 1 Receptor Antagonist-Telmisartan On The Occurrence And Development Of Esophageal Squamous Cell Carcinoma
40. Screening For PAF Receptor Antagonist And Study On Their Anti-angiogenesis Action And Mechanisms
  <<First  <Prev  Next>  Last>>  Jump to